Sitagliptin/metformin
| Combination of | |
|---|---|
| Sitagliptin | Dipeptidyl peptidase-4 inhibitor |
| Metformin | Biguanide |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | A10BD07 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
Sitagliptin/metformin (trade name Janumet) is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin.
This article is issued from Wikipedia - version of the 1/29/2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.